A Multicenter Study for the Validation of ALS Biomarkers

Research subjects are being recruited to participate in a specimen collection study enrolling under the direction of Dr. David Lacomis.

The purpose of the research study is to collect blood samples from healthy subjects, and both blood and cerebrospinal fluid (CSF) samples from people with amyotrophic lateral sclerosis (ALS), pure lower or upper motor neuron diseases, as well as other neurodegenerative diseases. Through comparison of these samples, the researchers hope to learn more about the underlying cause of ALS, as well as find unique biological markers, which could be used to develop new therapies. 

Participants must be at least 40 years of age and be able to answer brief questions about their medical and family history, as well as be willing to have blood and/or CSF drawn for the study.  If interested, please contact one of our coordinators at 412-647-1706. You may also contact the Coordination Center via the Northeast ALS Consortium (NEALS) for more information about this study at mghneuroclinicaltrialsunit@partners.org or toll free at 1-877-458-0631.